Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis

Journal of Rheumatology

Volumn 32, Issue 10, 2005, Pages 1888-1892

  Nietert, Paul J ^a,c   Silver, Richard M ^b   Mitchell, Holly C ^b   Shaftman, Stephanie R ^a   Tilley, Barbara C ^a  

^a Department of Biostatistics Bioinformatics and Epidemiology ^*  (United States)

^b Division of Rheumatology   (Puerto Rico)

^c Center for Health Care Research   (United States)

Author keywords

Continental population groups; Hospital mortality; Racial disparities; Systemic sclerosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CAUCASIAN; CAUSE OF DEATH; CHILD; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DEMOGRAPHY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; INFANT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEGRO; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; SOCIOECONOMICS; SYSTEMIC SCLEROSIS; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; DEMOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; SOUTH CAROLINA; SURVIVAL RATE;

EID: 26444457346     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Mayes MD, Lacey JV, Beebe-Dimmer J, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246-55.
2. Steen V. Changes in causes of death in systemic sclerosis over the past 30 years [abstract]. Arthritis Rheum 2004;50 Suppl:S422.
3. Scussel-Lonzetti L, Joyal F, Raynauld JP, et al. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine 2002;81:154-67.
4. Nishioka K, Katayama I, Kondo H, et al. Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc). Scleroderma Research Committee Japan. J Dermatol 1996;23:677-82.
5. Ruangjutipopan S, Kasitanon N, Louthrenoo W, Sukitawut W, Wichainun R. Causes of death and poor survival prognostic factors in Thai patients with systemic sclerosis. J Med Assoc Thai 2002;85:1204-9.
6. Bryan C, Knight C, Black CM, Silman AJ. Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum 1999;42:2660-5.
7. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005;118:2-10.
8. Nietert PJ, Silverstein MD, Silver RM. Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis. J Rheumatol 2001;28:2031-7.
9. Nietert PJ, Silver RM. Patterns of hospital admissions and emergency room visits among patients with scleroderma in South Carolina, USA. J Rheumatol 2003;30:1238-43.
10. Report on racial and ethnic disparities in health care. American Medical Association. [Internet]. Available from: http://www. ama-assn.org/ama/pub/ category/6925.html. Accessed June 29, 2005.
11. Nietert PJ, Sutherland SE, Silver RM, et al. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum 1998;41:1111-8.
12. Massey J. Using interviewer observed race and respondent reported race in the Health Interview Survey. Alexandria, VA: American Statistical Association; 1980.